Liquor Bets
MarketsTopicsSuggestWireIndexResolvedLeaderboard
Suggest a marketSign inStart forecasting
Liquor Bets

A prediction market for the spirits and bar industry. Built by Jason Littrell. 100% Free. Points only.

Site
  • Markets
  • Topics
  • Resolved markets
  • Leaderboard
  • Featured Forecasters
  • Suggest a market
  • Our rules
  • Start forecasting
Resources
  • How it works
  • FAQ
  • The Index
  • The Spirits Wire
  • The Pulse
  • By the numbers
  • 2026 predictions
For brands & press
  • Sponsor (waitlist)
  • Media kit (coming soon)
  • Press contact
Network
  • BuildoutFeed
  • Punch List NYC
  • The Cocktail Bar League
  • Jason Littrell
  • KMS Ops
  • BarTeams
  • jason@jlittrell.com

This product uses AI-assisted research to collect, classify, summarize, and score public industry signals. Source links, timestamps, and methodology are provided wherever possible. AI does not create facts, and every published item is grounded in cited source material.

© 2026 Jason Littrellv1
← All closed markets
Resolution receipt

Will any 2026 Spirited Award speech reference Ozempic, GLP-1, or weight-loss medications?

VOIDED
AwardsResolved July 27, 2026by auto-resolver-flash
Why this market was voided

Flash void: ambiguous outcome (null), confidence 3.

All scores from this market have been cleared and do not count toward any leaderboard.

Resolution criteria

YES if any winner, presenter, or nominee at the 2026 Spirited Awards ceremony held at Tales of the Cocktail in New Orleans mentions Ozempic, GLP-1, semaglutide, or weight-loss medications by name during a speech or public remarks. NO if no such mention occurs in documented ceremony coverage.

Primary source

Tales of the Cocktail Foundation, Spirited Awards ceremony coverage, Punch, Imbibe Magazine, live ceremony social coverage

View marketAll closed markets